会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Polyprenyl compounds and method of producing the same
    • 聚丙烯基化合物及其制备方法
    • US4564477A
    • 1986-01-14
    • US467253
    • 1983-02-17
    • Tetsuo TakigawaKoichi IbataMasafumi OkadaMasao MizunoTakashi Nishida
    • Tetsuo TakigawaKoichi IbataMasafumi OkadaMasao MizunoTakashi Nishida
    • C07C29/14C07C29/147C07C45/29C07C45/30C07C45/59C07C45/67C07C47/21C07C49/203C07C57/03C07C69/587C07D295/02C07D295/03C07D295/185C09F5/00
    • C07D295/185C07C255/00C07C29/14C07C29/147C07C45/292C07C45/298C07C45/305C07C45/59C07C45/676C07C47/21C07C49/203C07C57/03C07D295/03
    • There are provided polyprenyl compounds of the formula ##STR1## wherein ##STR2## represent a trans-isoprene unit and a cis-isoprene unit, respectively, n is an integer of 11-19, Z.sup.1 and Z.sup.2 combinedly represent .dbd.O, .dbd.CH--COOH,.dbd.CH--COOR.sup.1, .dbd.CH--CN, .dbd.C(CN)COOR.sup.2, .dbd.CH--CO--NH.sub.2, .dbd.CH--CO--N(R.sup.3) (R.sup.4), .dbd.CH--CO--NHR.sup.5, .dbd.CH--CH.sub.2 --N(R.sup.3) (R.sup.4), .dbd.CH--CH.sub.2 --NHR.sup.5 or .dbd.CH--CHO or Z.sup.1 is a hydrogen atom and Z.sup.2 is --CH.sub.2 COOH, --CH.sub.2 COOR.sup.6, --CH(CN)COOR.sup.2, --CH.sub.2 CN, --CH.sub.2 --CO--NH.sub.2, --CH.dbd.CH--N(R.sup.3) (R.sup.4) or --CH.sub.2 --CH.dbd.N--R.sup.5, R.sup.1, R.sup.2 and R.sup.6 each being a lower alkyl group, R.sup.3 and R.sup.4 each independently being a lower-alkyl, cycloalkyl, aryl or aralkyl group or R.sup.3 and R.sup.4 combinedly representing an alkylene group containing 2-5 carbon atoms, and R.sup.5 being a lower-alkyl, cycloalkyl, aryl or aralkyl group. These polyprenyl compounds can be synthesized starting with a polyprenol obtainable from leaves of a plant such as Ginkgo biloba or Cedrus deodara by extraction and as necessary followed by hydrolysis, or a reactive derivative thereof. The polyprenyl compounds are useful as intermediates for the synthesis of dolichol without the use of an expensive C.sub.5 chain extender.
    • 提供下式的聚异戊二烯基化合物:其中,“IMAGE”分别代表异戊二烯单元和顺式异戊二烯单元,n为11-19的整数,Z1和Z2组合表示 = CH 2 COOR 1 = CH-COOR 1 = CH-CN = C(CN)COOR 2 = CH-CO-NH 2 = CH-CO-N(R3)(R4) NHR 5,= CH-CH 2 -N(R 3)(R 4),= CH-CH 2 -NHR 5或= CH-CHO或Z 1是氢原子,Z 2是-CH 2 COOH,-CH 2 COOR 6,-CH(CN)COOR 2,-CH 2 CN ,-CH 2 -CO-NH 2,-CH = CH-N(R 3)(R 4)或-CH 2 -CH = N-R 5,R 1,R 2和R 6各自为低级烷基,R 3和R 4各自独立地为低级 - 烷基,环烷基,芳基或芳烷基或R3和R4组合表示含2-5个碳原子的亚烷基,R5为低级烷基,环烷基,芳基或芳烷基。 这些聚异戊二烯基化合物可以从通过提取从植物如银杏叶或Cedrus deodara的叶获得的聚异戊二烯开始合成,并且根据需要随后进行水解或其活性衍生物合成。 聚异戊二烯基化合物可用作合成Dolichol而不使用昂贵的C5扩链剂的中间体。
    • 7. 发明授权
    • Long chain carboxylic acid maleimides
    • 长链羧酸马来酰亚胺
    • US5360914A
    • 1994-11-01
    • US59759
    • 1993-05-11
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • A61K38/44C12N9/02A61K37/50C07D207/452C07K15/12
    • C12N9/0089
    • Provided are novel superoxide dismutase derivatives represented by the following general formula (I) ##STR1## wherein [SOD] is a superoxide dismutase residue derived by removal of two mercapto groups, and W is a divalent long chain hydrocarbon residue which may optionally be interrupted by one or more groups each independently selected from the group consisting of an oxygen atom, a sulfur atom and a group of -N(R)- (R being a lower alkyl group). The SOD derivatives retain most of the enzymatic activities of unmodified SOD and have much longer plasma half-life than unmodified SOD. They are effective for treating various diseases caused by active oxygen species.Also provided are chemical modifiers to prepare the above SOD derivatives.
    • 提供了由以下通式(I)表示的新型超氧化物歧化酶衍生物,其通过除去两个巯基衍生得到的酪蛋白酶残基,W是二价长链烃残基,其可以任选地被一个或多个各自独立地选自 由氧原子,硫原子和-N(R) - (R为低级烷基)的基团组成。 SOD衍生物保留大部分未修饰的SOD的酶活性,并且具有比未修饰的SOD更长的血浆半衰期。 它们对于治疗由活性氧引起的各种疾病是有效的。 还提供了制备上述SOD衍生物的化学改性剂。
    • 8. 发明授权
    • Superoxide dismutase derivatives
    • 超氧化物歧化酶衍生物
    • US5238837A
    • 1993-08-24
    • US803414
    • 1991-12-06
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • A61K38/44C12N9/02
    • C12N9/0089
    • Provided are novel superoxide dismutase derivatives represented by the following general formula (I) ##STR1## wherein [SOD] is a superoxide dismutase residue derived by removal of two mercapto groups, and W is a divalent long chain hydrocarbon residue which may optionally be interrupted by one or more groups each independently selected from the group consisting of an oxygen atom, a sulfur atom and a group of --N(R)-- (R being a lower alkyl group). The SOD derivatives retain most of the enzymatic activities of unmodified SOD and have much longer plasma half-life than unmodified SOD. They are effective for treating various diseases caused by active oxygen species.Also provided are chemical modifiers to prepare the above SOD derivatives.
    • 提供了由以下通式(I)表示的新型超氧化物歧化酶衍生物:其中[SOD]是通过除去两个巯基衍生的超氧化物歧化酶残基,W是可任意选择的二价长链烃残基 被一个或多个各自独立地选自氧原子,硫原子和-N(R) - (R是低级烷基)的基团的基团中断)。 SOD衍生物保留大部分未修饰的SOD的酶活性,并且具有比未修饰的SOD更长的血浆半衰期。 它们对于治疗由活性氧引起的各种疾病是有效的。 还提供了制备上述SOD衍生物的化学改性剂。
    • 10. 发明授权
    • Pregnane derivatives and processes for production thereof
    • PREGNANE衍生物及其生产方法
    • US5112998A
    • 1992-05-12
    • US545120
    • 1990-06-15
    • Jiro TsujiTakashi TakahashiMasao TsujiNaoshi NakagawaTetsuo Takigawa
    • Jiro TsujiTakashi TakahashiMasao TsujiNaoshi NakagawaTetsuo Takigawa
    • C07J9/00C07J17/00C07J41/00C07J51/00C07J71/00
    • C07J41/0055C07J17/00C07J51/00C07J71/001C07J9/00
    • There are provided pregnane derivatives represented by formula ##STR1## wherein A.sup.1 represents a hydrogen atom or a hydroxyl group, A.sup.2 represents a substituent such as a hydroxyl group when A.sup.1 represents a hydrogen atom, or A.sup.2 represents a hydrogen atom when A.sup.1 represents a hydroxyl group, or A.sup.1 and A.sup.2 are combined together to form an oxo group; D.sup.1 represents a substitutent such as a hydroxyl group, and D.sup.2 represents a hydrogen atom, or D.sup.1 and D.sup.2 are combined together to form an epoxy group or a single bond; D.sup.3, D.sup.5 and D.sup.7 each represents a hydrogen atom, D.sup.4 represents a hydroxyl group, and D.sup.6 represents a substitutent such as a hydroxyl group, or D.sup.3 and D.sup.4 may be combined together to form an epoxy group or a single bond, or D.sup.4 and D.sup.5 may be combined together to form a single bond, or D.sup.5 and D.sup.6 may be combined together to form an epoxy group or a single bond, or D.sup.6 and D.sup.7 may be combined together to form a singel bond; and X.sup.1 and X.sup.2 each represents a lower alkoxyl group or, when combined together, they represent a lower alkylenedioxy or oxo group, and a process for their preparation.The pregnane derivatives are useful as intermediates for synthesizing vitamin D.sub.3 derivatives having a hydroxyl group in the 1.alpha.-position.
    • PCT No.PCT / JP88 / 00313 Sec。 371日期1987年11月30日 102(e)1987年11月30日日期PCT提交1988年3月29日PCT公布。 出版物WO88 / 07545 提供了由式表示的孕烷衍生物,其中A1表示氢原子或羟基,当A1表示氢原子时,A2表示取代基如羟基,或A2表示氢 当A1表示羟基时,或A1和A2组合在一起形成氧代基; D1表示取代基,例如羟基,D2表示氢原子,或D1和D2组合在一起形成环氧基或单键; D3,D5和D7各自表示氢原子,D4表示羟基,D6表示取代基如羟基,或D3和D4可以组合在一起形成环氧基或单键,或D4和D5 可以组合在一起形成单键,或者D5和D6可以组合在一起以形成环氧基或单键,或者D6和D7可以组合在一起形成单键; 并且X 1和X 2各自表示低级烷氧基,或者当它们组合在一起时,它们代表低级亚烷基二氧基或氧代基团,及其制备方法。 孕烷衍生物可用作合成在1α位具有羟基的维生素D3衍生物的中间体。